Kite to acquire CAR T-cell therapy company Tmunity Therapeutics
The acquisition will complement Kite’s existing in-house research capabilities and provide Kite with rapid manufacturing processes, Armored CAR…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Dec 22
The acquisition will complement Kite’s existing in-house research capabilities and provide Kite with rapid manufacturing processes, Armored CAR…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Dec 22
To be renamed TAK-279 after the completion of the deal, NDI-034858 is being studied for the treatment of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Dec 22
The partnership combines GSK’s expertise in human genetics and genomics with Wave’s proprietary discovery and drug development oligonucleotide…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Dec 22
Horizon Therapeutics is a biotechnology company focused on discovering, developing, and marketing medicines that for rare, autoimmune, and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Nov 22
The transaction consideration includes an initial payment of $200m upon closing, and contingent milestones-based and non-contingent consideration of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
22 Nov 22
Merck, through its acquisition subsidiary, will initiate a tender offer to acquire all outstanding shares of Imago for…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Nov 22
The mRNA manufacturing plant is expected to create regional manufacturing capacities to support BioNTech’s pipeline of mRNA-based vaccines…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 Nov 22
The authorisation was based on findings of the SAVE-MORE phase 3 study which showed long-term benefits with improved…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 Nov 22
In the trial, the jury found that Lilly's migraine drug Emgality infringed three Teva patents and the infringements…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Nov 22
The approval was based on better survival results of Libtayo plus chemotherapy in comparison to chemotherapy alone in…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates